Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer DOI Open Access
Esma Eren, Joydeep Das, Trygve O. Tollefsbol

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(23), P. 4143 - 4143

Published: Nov. 29, 2024

Breast cancer poses a substantial health challenge for women globally. Recently, there has been notable increase in scholarly attention regarding polyphenols, primarily attributed to not only the adverse effects associated with conventional treatments but also their immune-preventive impacts. Polyphenols, nature-derived substances present vegetation, including fruits and vegetables, have received considerable various fields of science due probable wellness merits, particularly treatment hindrance cancer. This review focuses on immunomodulatory polyphenols breast cancer, emphasizing capacity influence reaction adaptive innate immune cells within tumor-associated environment. Polyphenols are implicated modulation inflammation, enhancement antioxidant defenses, promotion epigenetic modifications, support functions. Additionally, these compounds shown activity critical cells, macrophages T cells. By targeting pathways involved evasion, may augment defensive system detect eliminate tumors. The findings suggest that incorporating polyphenol-rich foods into diet could offer promising, collaborative (integrative) approach classical remedial procedures by regulating how defense mechanism interacts disease.

Language: Английский

Casticin inhibits proliferation of Non-small cell lung cancer cells through regulating reprogramming of glucose metabolism DOI
Jingyi Wei,

Guangyan Lei,

Qiang Chen

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 136, P. 156278 - 156278

Published: Nov. 23, 2024

Language: Английский

Citations

1

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy DOI Creative Commons
Yogesh Godiyal,

Drishti Maheshwari,

Hiroaki Taniguchi

et al.

Military Medical Research, Journal Year: 2024, Volume and Issue: 11(1)

Published: Dec. 18, 2024

Abstract Cancer is a global health problem and one of the leading causes mortality. Immune checkpoint inhibitors have revolutionized field oncology, emerging as powerful treatment strategy. A key pathway that has garnered considerable attention programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1). The interaction between PD-L1 expressed on tumor cells PD-1 reduces innate immune response thus compromises capability body’s system. Furthermore, it controls phenotype functionality adaptive components. range monoclonal antibodies, including avelumab, atezolizumab, camrelizumab, dostarlimab, durvalumab, sinitilimab, toripalimab, zimberelimab, been developed for targeting PD-L1. These agents can induce broad spectrum autoimmune-like complications may affect any organ Recent studies focused effect various natural compounds inhibit checkpoints. This could contribute to existing arsenal anticancer drugs. Several bioactive shown PD-1/PD-L1 signaling axis, promoting apoptosis, influencing proliferation, eventually inhibiting cancer progression. However, there substantial knowledge gap regarding role different in context cancer. Hence, this review aims provide common connection blockade effects distinct molecules. Moreover, primary focus will be underlying mechanism action well clinical efficacy Current challenges along with scope future research directions interactions through substances are also discussed.

Language: Английский

Citations

1

A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update DOI Creative Commons
Gabriel Samaşcă, Claudia Burz,

Irena Pintea

et al.

Pharmaceuticals, Journal Year: 2024, Volume and Issue: 17(9), P. 1121 - 1121

Published: Aug. 24, 2024

Researchers have performed numerous studies on immunotherapy because of the high death rate associated with gastric cancer (GC). GC research has made tremendous progress, and we wanted to provide an update this topic. On basis update, suggest performing a new medical evaluation before initiating in patients increase success immunotherapies. We propose that start immunotherapy, they should be evaluated given score one two points for following factors: immunopathological features, molecular genomic potential consequences bacterial pathogens, immunotherapeutic resistance hyperprogressive illness, use biomarkers gauge their prognosis responses optimize surgery. The proposed scoring system could also help diagnosis GC. With all advances genetics, immunology, microbiology, improved, not changed. Currently, diagnosed undergo surgical resection as only permanent solution. Patients who meet maximum from presented proposal eligible immediately after immunotherapy. Therefore, first-line option clinicians.

Language: Английский

Citations

0

The Chemopreventive Impact of Diet-Derived Phytochemicals on the Adipose Tissue and Breast Tumor Microenvironment Secretome DOI

Naoufal Akla,

Carolane Veilleux,

Borhane Annabi

et al.

Nutrition and Cancer, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 17

Published: Sept. 19, 2024

Cancer cells-derived extracellular vesicles can trigger the transformation of adipose-derived mesenchymal stem cells (ADMSC) into a pro-inflammatory, cancer-associated adipocyte (CAA) phenotype. Such secretome-mediated crosstalk between adipose tissue and tumor microenvironment (TME) therefore impacts progression metastatic processes. In addition, emerging roles diet-derived phytochemicals, especially epigallocatechin-3-gallate (EGCG) among other polyphenols, in modulating exosome-mediated metabolic inflammatory signaling pathways have been highlighted. Here, we discuss how selected phytochemicals could alter secretome signature as well dynamics TME, with focus on breast cancer. Their broader implication chemoprevention obesity-related cancers is also discussed.

Language: Английский

Citations

0

Nano-encapsulation of Epigallocatechin Gallate (EGCG) within Zeolitic Imidazolate Framework-8 (ZIF-8) and Controlled Release of EGCG (表没食子儿茶素没食子酸酯 (Egcg) 在沸石咪唑酯骨架-8 (Zif-8) 中的纳米封装以及 Egcg 的控制释放) DOI
Xiaozhen Chen,

Yuxian Feng,

Y.-B. Wei

et al.

Published: Jan. 1, 2024

Language: Английский

Citations

0

Polyphenols as Immunomodulators and Epigenetic Modulators: An Analysis of Their Role in the Treatment and Prevention of Breast Cancer DOI Open Access
Esma Eren, Joydeep Das, Trygve O. Tollefsbol

et al.

Nutrients, Journal Year: 2024, Volume and Issue: 16(23), P. 4143 - 4143

Published: Nov. 29, 2024

Breast cancer poses a substantial health challenge for women globally. Recently, there has been notable increase in scholarly attention regarding polyphenols, primarily attributed to not only the adverse effects associated with conventional treatments but also their immune-preventive impacts. Polyphenols, nature-derived substances present vegetation, including fruits and vegetables, have received considerable various fields of science due probable wellness merits, particularly treatment hindrance cancer. This review focuses on immunomodulatory polyphenols breast cancer, emphasizing capacity influence reaction adaptive innate immune cells within tumor-associated environment. Polyphenols are implicated modulation inflammation, enhancement antioxidant defenses, promotion epigenetic modifications, support functions. Additionally, these compounds shown activity critical cells, macrophages T cells. By targeting pathways involved evasion, may augment defensive system detect eliminate tumors. The findings suggest that incorporating polyphenol-rich foods into diet could offer promising, collaborative (integrative) approach classical remedial procedures by regulating how defense mechanism interacts disease.

Language: Английский

Citations

0